1. Home
  2. STBA vs KARD Comparison

STBA vs KARD Comparison

Compare STBA & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo S&T Bancorp Inc.

STBA

S&T Bancorp Inc.

HOLD

Current Price

$50.46

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Kardigan Inc. Common Stock

KARD

Kardigan Inc. Common Stock

N/A

Current Price

$20.91

Market Cap

1.8B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
STBA
KARD
Founded
1902
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
1995
2026

Fundamental Metrics

Financial Performance
Metric
STBA
KARD
Price
$50.46
$20.91
Analyst Decision
Hold
Analyst Count
6
0
Target Price
$43.00
N/A
AVG Volume (30 Days)
235.8K
185.2K
Earning Date
04-23-2026
N/A
Dividend Yield
3.29%
N/A
EPS Growth
2.35
N/A
EPS
1.96
N/A
Revenue
N/A
N/A
Revenue This Year
$10.20
N/A
Revenue Next Year
$4.14
N/A
P/E Ratio
$25.61
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.38
$19.58
52 Week High
$53.50
$27.00

Technical Indicators

Market Signals
Indicator
STBA
KARD
Relative Strength Index (RSI) 46.99 47.67
Support Level $48.99 $19.67
Resistance Level $53.50 $24.82
Average True Range (ATR) 0.72 1.40
MACD -0.31 0.07
Stochastic Oscillator 23.03 33.95

Price Performance

Historical Comparison
STBA
KARD

About STBA S&T Bancorp Inc.

S&T Bancorp Inc is a financial holding company providing a full range of financial services to individuals and businesses in Pennsylvania and Ohio, including retail and commercial banking products, cash management, and trust and brokerage services. Through its subsidiary, it offers consumer, commercial, and small business banking services, including time and demand deposits, commercial and consumer loans, brokerage and trust services, and manages private investment accounts for individuals and institutions. The company earns revenue mainly from interest on loans and securities and fees for financial services, with net interest income as the principal source of revenue, and incurs expenses for deposits, funding sources, provision for credit losses, and operating costs.

About KARD Kardigan Inc. Common Stock

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Share on Social Networks: